Vomikaynd solution for infection. 2mg/ml amp. 2 ml No. 4

Solution for injections Vomikaynd is shown:

• in nausea and vomiting, caused by cytotoxic chemotherapy and radiation therapy;
• for prevention and treatment of postoperative nausea and vomiting.

Structure

• active ingredient: ondansetron;
to
• 1 ml of an ondansetron a hydrochloride it is equivalent an ondansetrona of 2 mg;
• excipients: sodium chloride, citric acid, sodium, water for injections.

Use of an ondansetron together with Apomorphini Hydrochloridum is contraindicated to

Contraindication

Hypersensitivity to medicament components.

Route of administration

Nausea and vomiting caused by chemotherapy and radiation therapy.

depending on a dose and a combination of the modes of chemotherapy and radiation therapy. The choice of the mode of dosing depends on weight of emetogenny influence.

Feature of use

Pregnant

is not recommended to be applied during pregnancy.

Children

to children aged from 6 months (at chemotherapy) and aged from 1 month (to prevention and treatment of postoperative nausea and vomiting).

Drivers

Psychomotor tests showed that ondansetron does not affect ability to operate mechanisms and has no sedative effect, but it must be kept in mind a profile of side effects of medicament at the solution of a question of an opportunity to run motor transport or other mechanisms.

Overdose

Data on overdose of an ondansetron. In most cases symptoms are similar to those that are described at patients to whom entered the recommended doses (see the Section "Side reactions").

Ondansetron increases QT interval of dose-dependent to a form. In case of overdose carrying out ECG monitoring is recommended.

Among manifestations of overdose it is recorded visual disorders, a constipation of heavy degree, arterial hypotension, vazovagalny manifestations with tranzitorny AV blockade of the II degree. These phenomena completely passed in all cases.

children of younger age Have messages about cases of a serotoninovy syndrome after overdose reception.

Side reactions

from the immune system: seldom reactions of immediate hypersensitivity, sometimes heavy, up to an anaphylaxis.

from nervous system: very often - a headache; infrequently - spasms, motive disturbances (including extrapyramidal reactions, such as okulogirny crises, dystonic reactions and dyskinesia without resistant clinical consequences) it is rare - dizziness, mainly during fast administration of drug.

from an organ of sight: seldom - passing visual disorders (turbidity in eyes), mainly at intravenous administration; very seldom - a passing blindness, mainly during introduction (in most cases the blindness passes within 20 minutes).

Ondansetron does not accelerate

and does not slow down metabolism of other medicaments at use, simultaneous with it. Special researches showed what ondansetron does not interact with alcohol, temazepam, furosemide, Alfentanil, tramadoly, morphine, lidocaine, thiopental or propofoly.

Storage conditions

to Store

at a temperature not above 30 °C in original packing.

to Store

out of children's reach.

Expiration date. 2 years.